Under the models currently operated in Switzerland, Canada and Australia new medicines are usually received between 6 and 12 months after countries in the EU.Health and Sport Committee Official report 13 Mar 2018 COL 29
The Royal College of Physicians and Surgeons of Glasgow considered the best possible framework for future regulation lies in ongoing cooperation and partnership between the MHRA and the EMA, as this would provide the best possible opportunity for patients and clinicians.The Royal College of Physicians and Surgeons of Glasgow written submission The Royal Pharmaceutical Society Scotland indicated the UK should “seek to retain its position as an EMA Reference Member State”.The Royal Pharmaceutical Society Scotland written submission
Another way forward would be through a mutual recognition agreement.